Hims & Hers Health, Inc. current report, 17 July 2019

Business Context and Reporting Period

This Form 8-K was filed by Oaktree Acquisition Corp., not Hims & Hers Health, Inc. The report concerns the company’s initial public offering and related transactions. The earliest reported event date was July 17, 2019; the IPO and related agreements were consummated on July 22, 2019, and the report was signed on July 23, 2019.

Key Financial and Capitalization Metrics

  • The company issued 20,125,000 units at $10.00 per unit, generating gross IPO proceeds of $201.25 million.
  • Each unit included one Class A ordinary share and one-third of a redeemable warrant. Each whole public warrant is exercisable for one Class A ordinary share at $11.50 per share.
  • The sponsor purchased 4,016,667 private placement warrants at $1.50 per warrant, generating proceeds of $6.025 million.
  • Net IPO proceeds and certain private-placement proceeds were placed in a trust account. The filing text does not provide a clear value for net proceeds, cash flow, operating expenses, profit, margins, debt, or liquidity outside the trust structure.
  • The sponsor agreed to provide office space and administrative support for $10,000 per month until the initial business combination or liquidation.

Material Changes Versus the Prior Comparable Period

The filing does not present comparative financial statements or prior-period operating results. The material developments were the effectiveness of the IPO registration statement, completion of the IPO, completion of the private placement, and execution of related trust, warrant, registration-rights, governance, and administrative agreements.

Guidance, Outlook, Risks, and Unusual Items

  • The company is a special purpose acquisition company and had not identified an operating business or reported operating performance in this filing.
  • The company is required to pursue an initial business combination and has agreed to facilitate liquidation if a business combination is not completed within 24 months.
  • Officers, directors, and the sponsor agreed to vote their Class A ordinary shares in favor of the initial business combination, subject to the applicable agreements.
  • Public and private warrants contain redemption, exercise, transfer-restriction, and adjustment provisions. Private placement warrants have additional rights while held by the sponsor or permitted transferees, including cashless exercise and exemptions from certain redemption provisions.
  • Funds in the trust account are subject to the withdrawal and direction provisions of the investment management trust agreement. Failure to complete a business combination within the required period could result in liquidation.

Important Facts for Investors to Verify

  • Confirm that the filing issuer is Oaktree Acquisition Corp. and not Hims & Hers Health, Inc.
  • Review the trust-account balance, permitted withdrawals, redemption mechanics, and liquidation provisions.
  • Verify the 20,125,000 units, $201.25 million gross IPO proceeds, and $6.025 million private-placement proceeds.
  • Review the warrant agreement for exercise, redemption, cashless-exercise, and adjustment terms.
  • Assess the 24-month deadline and the sponsor’s voting, indemnification, transfer-restriction, and registration-rights obligations.